Overexpression of cortactin/CTTN is linked to metastatic disease in head and neck cancer, breast cancer, oesophageal cancer, hepatocellular carcinoma, melanoma and colorectal cancer32–39. Here, CTTN is linked to carcinoma of esophagus.